Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04859699 · ClinicalTrials.gov registry record · NA
Reopening Schools Safely and Educating Youth Research Study (ROSSEY)
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 1,095
- Enrollment target
NCT04859699: Completed NA study, sponsored by University of Washington.
NCT04859699 is a NA study that has completed, run by University of Washington. The registered enrollment target is 1,095 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (22% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04859699, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,095 participants
- Enrollment target
Study Summary
The study has three aims and involves a clustered randomized controlled trial (RCT) where K-5 schools will be the unit of randomization. Aim 1 involves a qualitative assessment of rural Latino community's social, ethical, behavioral needs and resources for students to return to school and maintain onsite learning. Aim 2 includes a clustered RCT in schools. Aim 3 involves qualitative assessment of implementation outcomes of the Yakima School District (YSD) testing program and risk communication intervention with school stakeholders, parents, and children.
Primary Outcome
How many school days missed due to symptoms of respiratory illness (only include index child).
Interventions
- BEHAVIORAL COVID-19 Health Education Comic Books and Videos
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,095 participants |
| Start Date | 2022-01-17 |
| Est. Completion | 2024-12-31 |
| Phase | NA |
What the finished NCT04859699 record still lists
NCT04859699 is an interventional study that assigns participants to a tested intervention. Its 1,095 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (22% lower).
The record links to 0 conditions, and to 1 intervention - of which COVID-19 Health Education Comic Books and Videos is the first listed.
NCT04859699 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04859699 about?
NCT04859699 is a clinical study titled "Reopening Schools Safely and Educating Youth Research Study (ROSSEY)". The study has three aims and involves a clustered randomized controlled trial (RCT) where K-5 schools will be the unit of randomization. Aim 1 involves a qualitative assessment of rural Latino community's social, ethical, behavioral needs and resources for students to return to school and maintain o...
What is the current status of trial NCT04859699?
This trial is currently completed. It is a NA study. The enrollment target is 1,095 participants. The study started on 2022-01-17. Estimated completion is 2024-12-31.
What interventions are being tested in trial NCT04859699?
The interventions under investigation include: COVID-19 Health Education Comic Books and Videos (BEHAVIORAL).
Who is sponsoring clinical trial NCT04859699?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04859699's enrollment target sits among peer trials
1,095 95th of 2000 higher than 1,906 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06191744 · 1,095 participants · Phase 3
Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma
- NCT03754114 · 1,094 participants · NA
Brain Oxygen Optimization in Severe TBI, Phase 3
- NCT06118983 · 1,094 participants · NA
Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe (I-TRANSFER-HF)
- NCT06585241 · 1,094 participants · Phase 4
A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI